PharmChem, Inc.
PCHM · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $14,557 | $14,187 | $15,663 | $16,964 |
| - Cash | $2,018 | $1,629 | $2,479 | $2,304 |
| + Debt | $44 | $51 | $58 | $64 |
| Enterprise Value | $12,582 | $12,609 | $13,242 | $14,724 |
| Revenue | $1,580 | $1,522 | $1,575 | $1,542 |
| % Growth | 3.8% | -3.3% | 2.2% | – |
| Gross Profit | $1,015 | $972 | $1,017 | $1,005 |
| % Margin | 64.2% | 63.9% | 64.6% | 65.2% |
| EBITDA | $368 | $402 | $451 | $678 |
| % Margin | 23.3% | 26.4% | 28.6% | 44% |
| Net Income | $272 | $298 | $352 | $572 |
| % Margin | 17.2% | 19.6% | 22.4% | 37.1% |
| EPS Diluted | 0.059 | 0.064 | 0.076 | 0.12 |
| % Growth | -8.4% | -15.3% | -36.8% | – |
| Operating Cash Flow | $400 | $395 | $175 | $504 |
| Capital Expenditures | -$11 | -$0 | -$1 | -$1 |
| Free Cash Flow | $389 | $395 | $174 | $503 |